174 filings
Page 2 of 9
8-K
j07ivdmwt4rytmw2
21 Sep 22
Precigen Names Rutul R. Shah Chief Operating Officer
5:07pm
8-K/A
xmwir0
24 Aug 22
Financial Statements and Exhibits
4:28pm
8-K
fh63l
22 Aug 22
Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics
8:47am
8-K
xsx0we ktvytsxgrd
9 Aug 22
Entry into a Material Definitive Agreement
12:00am
8-K
hy53env ktw
8 Aug 22
Precigen Reports Second Quarter and First Half 2022 Financial Results
4:10pm
8-K
0xgjxspa8lw
13 Jul 22
Other Events
4:14pm
8-K
9wyadv
5 Jul 22
Precigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova Genetics
8:25am
8-K
ogq4bf0ckj5xmes99k
14 Jun 22
Submission of Matters to a Vote of Security Holders
4:21pm
8-K
cwgrdqad
9 May 22
Precigen Reports First Quarter 2022 Financial Results and Business Updates
4:14pm
8-K
8k3ureu3lmn zq
1 Mar 22
Precigen Reports Fourth Quarter and Full Year 2021 Financial Results
8:14am
8-K
w02tpbrws8y ufp
4 Nov 21
Precigen Achieves Significant Clinical Progress for UltraCAR-TĀ® and AdenoVerseā¢ Therapies
9:29am
8-K
dy4kxkrs94ixd 2ahu6c
12 Oct 21
Precigen Appoints Harry Thomasian Jr. as Chief Financial Officer
8:10am
8-K
oei3pa69a2 9088mphr4
9 Aug 21
Precigen Reports Second Quarter and First Half 2021 Financial Results
4:03pm
8-K
vvxibof4s 8x2qmn
15 Jun 21
Submission of Matters to a Vote of Security Holders
4:21pm
8-K
rleeb7f f1eosqw1d
28 May 21
Departure of Directors or Certain Officers
6:12am
8-K
jph8nau 5pdt
10 May 21
Precigen Reports First Quarter 2021 Financial Results
4:44pm
8-K
qt6w70
30 Mar 21
Precigen Announces Departure of Chief Financial Officer
12:00am
8-K
fa1o5uux
1 Mar 21
Precigen Reports Fourth Quarter and Full Year 2020 Financial Results
4:18pm
8-K
po46ot
26 Jan 21
Entry into a Material Definitive Agreement
4:13pm
8-K
cu3 0shxl020t13uel
13 Jan 21
Regulation FD Disclosure
4:32pm